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Abstract
Sadness is an emotion universally recognized across cultures, suggesting it plays an important 
functional role in regulating human behavior. Numerous adaptive explanations of persistent 
sadness interfering with daily functioning (hereafter “depression”) have been proposed, but most 
do not explain frequent bidirectional associations between depression and greater immune 
activation. Here we test several predictions of the host defense hypothesis, which posits that 
depression is part of a broader coordinated evolved response to infection or tissue injury (i.e. 
“sickness behavior”) that promotes energy conservation and reallocation to facilitate immune 
activation. In a high pathogen population of lean and relatively egalitarian Bolivian 
foragerhorticulturalists, we test whether depression and its symptoms are associated with greater 
baseline concentration of immune biomarkers reliably associated with depression in Western 
populations (i.e. tumor necrosis factor alpha [TNF-α], interleukin-1 beta [IL-1β], interleukin-6 
[IL-6], and C-reactive protein [CRP]). We also test whether greater pro-inflammatory cytokine 
responses to ex vivo antigen stimulation are associated with depression and its symptoms, which is 
expected if depression facilitates immune activation. These predictions are largely supported in a 
sample of older adult Tsimane (mean±SD age=53.2±11.0, range=34-85, n=649) after adjusting for 
potential confounders. Emotional, cognitive and somatic symptoms of depression are each 
associated with greater immune activation, both at baseline and in response to ex vivo stimulation. 
The association between depression and greater immune activation is therefore not unique to 
Western populations. While our findings are not predicted by other adaptive hypotheses of 
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depression, they are not incompatible with those hypotheses and future research is necessary to 
isolate and test competing predictions.
Keywords
depression; sickness behavior; immune activation; host defense; evolution; Tsimane
1. Introduction
Sadness is an emotion universally recognized across cultures (1), suggesting it plays an 
important functional role in regulating human behavior. Darwin hypothesized that emotion 
and mood evolved to motivate responses to recurring adaptive problems (2). Positive 
valence motivates continuation of prior behavior associated with its occurrence, while 
negative valence motivates disengagement and pursuit of alternative strategies (3). 
Numerous adaptive explanations of persistent sadness interfering with daily functioning 
(hereafter “depression”) have been proposed that build on Darwin's insights, yet the high 
prevalence of depressogenic risk alleles remains an evolutionary conundrum given the 
economic and social costs of depression worldwide (4). Many adaptive explanations posit 
social benefits to depression, including improving one's ability to solve social problems 
through rumination (5), compelling the loser of a conflict to avoid greater costs by signaling 
submission (6), avoiding exclusion from vital social relationships (7), and soliciting greater 
investment from a social partner by imposing costs on that partner (the “labor strike” 
hypothesis) (8). According to these explanations vegetative symptoms often associated with 
depression (e.g. tiredness, anhedonia, feelings of uselessness) facilitate energy conservation 
and reallocation to solve fitness-relevant social problems. Depression may also disengage 
motivation from unreachable goals (social or other), perhaps explaining its occurrence when 
achievements fail to meet expectations (9, 10).
Another adaptive explanation, the “host defense hypothesis” (11-13), similarly argues that 
depression functions to conserve and reallocate energy, but does not posit a social benefit or 
direct role in regulating nonsocial goal pursuits. According to the host defense hypothesis 
depression is a part of “sickness behavior”, i.e., one component of a broader coordinated 
adaptive response to infection or tissue injury (14). Innate immune cells produce pro-
inflammatory cytokines that act on the brain via endocrine, circulatory and nervous system 
pathways to promote sickness behaviors (e.g. anorexia). It is hypothesized that infection or 
injury induces depression, and that depression promotes energy conservation and 
reallocation to facilitate innate or adaptive immune activation in response. Secondary 
proposed benefits are that depression reduces risk of transmitting infection to kin and valued 
conspecifics via social withdrawal, and that depression reduces risk of acquiring novel 
infection or sustaining injury during periods of greater immune activation via risk aversion. 
It is also proposed that psychosocial stressors – many of which involve social rejection, 
interpersonal loss or conflict and strongly increase risk of depression throughout life – up-
regulate components of the innate immune system involved in inflammation because over 
evolutionary history these stressors reliably portended increased risk of pathogen exposure 
(e.g. via wounding or ostracism) (12, 15). This helps provide a host defense explanation for 
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why psychosocial stress (real, anticipated or imagined) is inflammatory. Unlike the other 
adaptive hypotheses described above, the host defense hypothesis uniquely predicts that 
depression is associated with indicators of morbidity (e.g. inflammation), and that depressed 
individuals exhibit greater immune responses to challenge than non-depressed individuals 
(all else equal).
Several indirect lines of evidence support these predictions. Depressive symptoms are 
consistently associated with inflammation (and vice versa) in nonhuman animal models, 
human clinical samples, experiments among healthy volunteers, and large-scale naturalistic 
studies in Western populations (16-18). Mice or rats administered high loads of certain pro-
inflammatory cytokines (e.g. interferon alpha [IFN-α]) present depressive-like symptoms 
such as decreased motor activity and reduced interest in eating or sex in a dose- and time-
dependent manner, and these symptoms are attenuated with repeated anti-depressant 
treatment (19, 20). Among healthy men, typhoid but not placebo injection yields an 
inflammatory response indicated by greater circulating interleukin-6 (IL-6), and mood 
reduction at three hours post-injection (21). This mood reduction is not associated with 
increased salivary cortisol or self-reported illness symptoms, suggesting a direct link to IL-6 
response; mood reduction is also correlated with enhanced activity in brain regions 
implicated in the etiology of depression. Similarly, among healthy men and women, 
Escherichia coli-derived endotoxin but not placebo administration yields greater IL-6 and 
tumor necrosis factor alpha (TNF-α) concentrations, and greater feelings of depression and 
social disconnection (22). Among hepatitis C patients receiving IFN-α immunotherapy, 
depressive symptoms develop even in the absence of a history of mental disorder (23). 
Moreover, depression risk alleles identified by candidate gene and genome-wide association 
studies are associated with alleles promoting innate and adaptive immunity (12). The types 
of pro-inflammatory genotypes that are over-represented in depressed samples may, in fact, 
confer enhanced survivorship in high pathogen environments while reducing survivorship 
when pathogenic exposures are minimized (24, 25). Although direct evidence that 
depression induces greater immune activation in response to infection or injury is scant, 
immune profiles of clinically depressed individuals show strong similarities to the acute 
phase response that is characterized by an activated innate immune system including 
elevated blood concentrations of inflammatory biomarkers (18, 26).
The acute phase response is a highly conserved part of innate immunity that initiates 
inflammation, clears pathogens and facilitates recovery from infection or injury. Local 
innate immune cells including monocytes and macrophages produce pro-inflammatory 
cytokines (e.g. IL-6, TNF-α, interleukin-1 beta [IL-1β]) that exert local and systemic effects 
such as recruiting leukocytes and modifying acute phase protein (e.g. C-reactive protein 
[CRP]) production in the liver. Fever is common within a few hours, as it can inhibit 
pathogen replication, conserve body heat, and potentiate innate or adaptive immunity (13). 
Lethargy and reduced interest in performing daily activities (e.g. eating, grooming) are 
common behavioral correlates of sickness. This coordinated adaptive response is costly: 
among adults with febrile illnesses (e.g. pulmonary tuberculosis, arthritis), resting metabolic 
rate (RMR) increases by 7-15% per 1°C rise in body temperature under febrile versus 
afebrile conditions (13, 27). Even in the absence of fever and chronic disease RMR 
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increases by 8-14% during respiratory infection (28). In addition to energetic costs, other 
potential costs of sickness behavior include by-products of prolonged immune activation 
(e.g. tissue catabolism), and opportunity costs of foregone productivity or sociality due to 
lethargy or social withdrawal. Given these costs sickness behavior usually dissipates once 
the infection is cleared or injury healed.
However, unlike most sickness behaviors depression is not necessarily reversible once a 
pathogen clears or injury heals. In addition, certain depressive symptoms including suicidal 
ideation are not easily explained by the notion that depression is an adaptation to protect the 
host from infection or injury (29). Other lines of evidence are not consistent with the host 
defense hypothesis, and suggest that depression may be a maladaptive consequence of 
cytokine-induced sickness (30). Depression is often associated with immune dysregulation 
such as delayed mucosal wound healing (31) and reduced cellular immunity (32). The 
“immune dysregulation hypothesis” posits that reduced infectious microbial exposure during 
development in Western populations contributes to insufficient anti-inflammatory signaling, 
which increases baseline levels of depressogenic cytokines, promotes hyper-inflammatory 
responses to psychosocial or other stressors, and induces depression (33). In the Philippines, 
where infections are more common than in Western populations, depression is not 
associated with IL-6 or CRP among younger or older adults (34). Infectious exposures 
during sensitive periods of immune development may promote efficient immune responses, 
which might preclude a persistent association between depression and greater immune 
activation in non-Western populations with heavier infectious burden. This logic and 
evidence do not support the hypothesis that depression serves an adaptive 
immunomodulatory role that is precipitated by infection or injury. Rather, any prolonged 
pro-inflammatory state characteristic of immune dysregulation might lead to a greater 
incidence of depression (35). Moreover, among healthy US adults, positive affect 
prospectively predicts higher helper T lymphocyte counts and greater natural killer cell 
cytotoxicity after controlling for potential confounders (36). Yet all else equal, the host 
defense hypothesis predicts that negative affect potentiates immunity because over 
evolutionary history the types of immune responses associated with depression should have 
provided, on average, enhanced immune protection against the pathogens most likely to 
have reduced survival and reproduction. It therefore remains unclear whether depression is 
associated with greater immune activation in highly pathogenic environments, and whether 
depression is an adaptive component of sickness behavior.
1.1. Study goals and predictions
Here we test the host defense hypothesis of depression in a high pathogen population of 
Bolivian forager-horticulturalists. Studying mood variation in small-scale societies, which 
possess similar socio-ecological features typical of the vast majority of human evolutionary 
history (see below, this paragraph), provides unique insight into the costs and benefits 
implied by the different adaptive models of depression. Among Tsimane Amerindians, the 
population studied here, comorbidity with infections from multiple sources (e.g. bacterial, 
viral) is prevalent and levels of immune activation are high throughout life relative to 
Westerners (37-41). Thus we can examine whether links between depression and immune 
activation exist in a population with sufficient “priming” of the immune system during 
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development. Aside from inadequate pathogenic exposure in development, other features of 
Western lifestyles – low physical activity level, high prevalence of metabolic disorder, and 
high levels of psychosocial stress from economic inequality, intense social competition 
and/or residential isolation from kin – have led researchers to posit that depression may be a 
maladaptive by-product of modernity (42-46). If depression is not a “disease of civilization” 
but instead an adaptive response to conditions regularly experienced over human 
evolutionary history, then it should be readily observable in small-scale subsistence societies 
like the Tsimane, which are physically active (47), lean (37), relatively egalitarian given a 
lack of defensible material possessions (48), and kin-oriented given high fertility, kin-based 
residence, and frequent resource transfers across households (49).
We test whether depression in adulthood is associated with greater baseline immune 
activation (P1), indicated by serum concentrations of TNF-α, IL-1β, IL-6 and CRP, as meta-
analyses report reliable associations between depression and these biomarkers in Western 
populations (50, 51). We examine whether energetic status moderates the relationship 
between depression and immune activation, as individuals with fewer energy stores may 
especially benefit from depression-induced energy conservation and reallocation (P2). On 
the other hand, reduced energetic status among Tsimane may co-occur with other stressors 
(e.g. food insecurity, physical limitations impeding subsistence work), which may result in 
depression regardless of infectious status (52, 53).
We also explore whether individual depressive symptoms are associated with greater 
baseline immune activation. Depression is a collection of different types of symptoms which 
may vary in their functions (e.g. tiredness directly promotes energy conservation; pessimism 
reduces motivation to pursue an unreachable goal). Symptom profiles may differ depending 
upon the kind of situation that precipitated depression (54, 55), and whether emotional, 
cognitive, and somatic symptoms are each associated with greater immune activation is 
unclear. Symptoms directly promoting energy conservation (e.g. tiredness) may be more 
strongly linked to immune activation than symptoms that are indirectly or not implicated in 
down-regulating activity levels (e.g. suicidal ideation, nervousness). On the other hand, if 
symptoms co-occur as part of a coordinated adaptive response across multiple inter-related 
physiological systems, then consistent links between individual symptoms and immune 
activation may not be so apparent. We therefore adopt an exploratory approach to analysing 
links between individual symptoms and immune activation, as the host defense hypothesis 
makes no explicit predictions.
Finally, we test whether greater cytokine (TNF-α, IL-1β, IL-6) responses to ex vivo whole 
blood antigen stimulation with the antigens lipopolysaccharides (LPS) and 
phytohaemagglutinin (PHA) are associated with depression in adulthood (P3). If depression 
facilitates greater immune activation as part of the host defense response to infection or 
injury, then depressed individuals should show greater cytokine responses to immune 
challenges compared to non-depressed individuals (all else equal). LPS is a cell wall 
component of gram negative bacteria that induces a B-cell response similar to that generated 
by gram negative bacteria, while PHA initiates a T-cell mediated response similar to that 
generated by viral infection (56-58). This quasi-experimental approach has several 
advantages, including the ability to examine whether depression may affect host responses 
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to multiple pathogens. More importantly, by stimulating cytokine responses ex vivo we are 
able to make inter-individual comparisons in immune activation which would otherwise be 
impossible or unethical while controlling for potential confounders (e.g. baseline immune 
activation). We also explore whether greater cytokine responses to antigen stimulation are 
associated with individual depressive symptoms. If depression is indeed part of a broader 
coordinated adaptive reaction to infection or injury, then greater immune response to 
challenge may be associated with emotional, cognitive and somatic symptoms.
2. Materials and methods
2.1. Study population
Tsimane (population ~15,000) inhabit 90+ villages that vary in proximity to the market town 
of San Borja (population ~25,000) in the Beni Department of lowland Bolivia. Related 
families co-reside in clusters of closely-spaced houses, and jointly produce and consume 
food. Most of the diet comes from horticulture (66% of calories), hunting (17%), fishing 
(7%), and fruits and nuts gathered from the forest (6%) (59). Tsimane have relatively short 
life expectancy (e0=42 years, e15=57, e45=66), high fertility (total fertility rate=9 births per 
woman) and physical work load (~5-6 hours/day spent in lifestyle-moderate activity), and 
minimal access to modern healthcare, sanitation and electricity. Tsimane recognize a mood 
state that approximates depression (yoquedye’) and often attribute its onset to musing over 
chronic illness (self or kin), death of a loved one, or extreme poverty compared to market-
integrated Bolivian nationals (napo'in). Suicide associated with persistent sadness has been 
documented. To the best of our knowledge no participant has ever taken prescription 
medication to treat depression.
2.2. Depression interview
We developed an interview based on focus groups, 10+ years of ethnographic experience, 
and a review of validated depression scales used among diverse samples with good test-
retest reliability (Beck's Depression Inventory, Hamilton Depression Rating Scale, and 
Center for Epidemiologic Studies Depression Scale) (52, 53). The 18-item interview 
contains most or all of the symptoms contained in previous scales, although two items 
(irritability and indecision) were omitted from analyses because neither was strongly 
correlated with any other item and mean item scores were low. The interview was translated 
from Spanish into Tsimane by two bilingual Tsimane research assistants. To test translation 
accuracy the Tsimane interview was back-translated into Spanish by a different Tsimane 
researcher, and discussions among the three Tsimane ensued until a translation was found 
that captured the essence of each item. To minimize recall bias, participants were queried 
about prevalence of symptoms over the past month. Responses were given on an anchored 
scale where 1 corresponds to “rarely,” 2 to “occasionally,” 3 to “often,” and 4 to “always” 
experiences symptom. Symptoms contain either emotional (two symptoms), somatic (three), 
cognitive (eight), or both cognitive and somatic (three) components.
Few participants were new to formal interviews because of their continuous participation in 
the Tsimane Health and Life History Project (THLHP) since 2002. Our long-term presence 
has helped establish trusting and collaborative relationships with Tsimane. Interviews were 
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conducted in a private location in the Tsimane language by a Tsimane researcher with 
multiple years of relevant experience on the THLHP. Internal consistency of the 16-items 
surpasses the standard benchmark of 0.7 (Cronbach's α=0.72). The 16 items were summed 
to create a “depression score” (mean±SD=38.7±6.6, range: 22-59), and scores are normally 
distributed for each sex (53). After the interview, the interviewer used the same 4-point 
anchored scale to rate a subset of respondents based on his observations of the extent to 
which the respondent was laughing and smiling (jovial) while participating in other THLHP 
interviews (~45 minutes in total). This was done to assess external validity of the interview, 
as joviality can reflect mood. Depression scores were correlated with joviality in the 
expected negative direction (Spearman's =−0.42, p=0.003, n=48).
Adults were recruited regardless of their health status. Older adults are over-represented 
given the THLHP's focus on aging. Mean±SD age in the sample is 53.2±11.0 
(range=34-85). Interviews were conducted from 2011-2012 at the THLHP's San Borja 
health clinic. Adults were transported from their villages (n=649 adults across 60 villages) to 
the clinic for a three-day stay to participate in this and other studies requiring more 
controlled conditions (see next section). All methods were approved by Institutional Review 
Boards at UNM and UCSB, and by the Tsimane government, village leaders and study 
participants.
2.3. Biomarkers of immune activation
Morning fasting blood specimens were collected by venipuncture during medical exams 
conducted at the THLHP's clinic during each participant's three-day stay. Samples were 
collected and prepared by a trained THLHP biotechnician with multiple years of relevant 
experience on the THLHP. After sample collection leukocyte counts were conducted 
manually. Two 100 μL aliquots of heparinized whole blood were added to separate round 
bottom microtiter wells in a sterile 96-well plate. The first aliquot received 100 μL of LPS 
(Sigma-Aldrich cat. L2630) diluted in RPMI (RPMI-1640 with 100 U/mL penicillin, 100 
μg/mL streptomycin, 1mM pyruvate, and 2mM L-glutamate) to 10 μg/mL. The second 
aliquot received 100 μL of PHA (Sigma-Aldrich cat. 61764) diluted in RPMI to 10 ng/mL. 
In the absence of a CO2 incubator, the microtiter plate was sealed in a glass Tupperware 
with a lit candle, which burned the O2 in the container, enriching the CO2 concentration 
(60). The remaining unstimulated portion of whole blood was allowed to clot, and then 
serum was separated via centrifugation (1500 g × 10 minutes) and frozen in liquid nitrogen. 
The sealed plate was incubated for 72 hours at 37°C. Afterward, the supernatant was 
aliquoted into cryovials and frozen in liquid nitrogen for transport to UNM. Specimens were 
transported on dry ice and stored at −80°C for up to two years before assay.
At UNM's Hominoid Reproductive Ecology Lab, TNF-α, IL-1β and IL-6 were analyzed 
using the Milliplex MAP High-Sensitivity 13-plex Human Cytokine Panel (Millipore, 
Billerica, MA, HSCYTO-60) on the Luminex MagPix Instrument and Millipore Analyst 
Software. The limit of detection was at least 0.05 pg/mL for TNF-α, 0.06 pg/mL for IL-1β, 
and 0.10 pg/mL for IL-6. Standards were prepared with a serum matrix for analysis of 
unstimulated samples, and with RPMI for antigen-stimulated samples. Quality control 
samples were within expected ranges provided by the manufacturer (CVs are not reported 
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for each cytokine but are available upon request). Due to a combination of logistical 
difficulties associated with obtaining reagents, cost, and sample volume constraints, 
stimulations were run on a random subset of specimens (see Table 1 for sample sizes).
CRP was measured at UCSB's Human Biodemography Lab with an enzyme immunoassay 
described elsewhere (61). The limit of detection was 0.07 mg/L and the CVs were 7.3% and 
10.2% for the high and 5.3% and 9.2% for the low controls. Due to resource constraints 
CRP assays were run on a random subset of specimens that was larger than the antigen 
stimulation subset.
2.4. Demographics and anthropometrics
Birth years were assigned based on a combination of methods including using known ages 
from written records, relative age lists, dated events, photo comparisons of people with 
known ages, and cross-validation of information from independent interviews of kin (62). 
Height and weight were measured during medical exams using a Seca stadiometer (Road 
Rod 214) and Tanita scale (BF680). Thirteen pregnant women were excluded from analysis 
due to potential confounding effects of pregnancy on immune activation.
2.5. Data analysis
In bivariate analyses depression is operationalized dichotomously to describe the sample and 
preliminarily assess potential threshold effects. A depression score cut-off of 48 indicates a 
mean item score ≥3, i.e. “often” experiencing symptom. Mann-Whitney U and chi-square 
tests are used to compare immune activation biomarkers, demographics, anthropometrics, 
and depression item scores by depression score cut-off. In multivariate analyses depression 
is operationalized continuously (summed 16 items). Most individuals contributed one data 
point but a random subset (<4%, n=23 individuals) contributed two data points to the 
analyses reported in sections 3.1-3.4 since they received two medical exams during the study 
period (one per year). These repeated measures are included in analyses to avoid 
unnecessarily reducing sample sizes, and because parameter estimates from multivariate 
analyses are directly comparable to those omitting repeated measures. Generalized 
estimating equations (GEE) analyses are used to model the effect of unstimulated immune 
activation biomarkers (TNF-α, IL-1β, IL-6 and CRP) on depression score after adjusting for 
potential confounders (section 3.3). The GEE method accounts for the correlated structure of 
dependent variables arising from repeated measures over time, controlling for each 
individual (63). GEE analyses of depression score as an outcome specify an exchangeable 
correlation structure, and parameter estimates are reported as standardized betas. To model 
the effect of unstimulated immune biomarkers on depression item score (section 3.4), GEE 
analyses specify a multinomial distribution. Cumulative logit estimates are converted to 
odds ratios (ORs), representing change in odds of reporting “always” experiencing a 
symptom compared to “rarely” (baseline) per SD increase in biomarker concentration. There 
is no standard absolute goodness-offit measure with the GEE method. Models of item scores 
as outcomes were also run using binary logistic regression (modelling the probability of 
reporting “always” experiencing a symptom or not), although no major differences with the 
multinomial models were found.
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Ordinary least squares (OLS) regression is used to model the effects of depression score 
(section 3.5) and item scores (section 3.6) on cytokine response to ex vivo antigen 
stimulation. Depression score (or each item score) is entered as a predictor rather than an 
outcome (as described above) given the role of depression in regulating responses to 
immune challenges as specified by the host defense hypothesis. We compared effect sizes 
using both stimulated cytokine values and change in stimulated values from baseline but no 
major differences were found (estimates are reported using the former outcome). Stimulated 
cytokine values were analyzed with and without standardization for leukocyte count 
(estimates are reported using both outcomes), to account for the fact that individuals with 
higher leukocyte counts may naturally show greater cytokine responses to antigen 
stimulation. Stimulations were run in batches collected on a given day, and while there is 
potential for a “batch effect” (e.g. from non-independence due to plate characteristics), 
inclusion of a random effect of batch ID in OLS regressions does not change results and is 
thus omitted. For all regressions, despite conducting multiple tests (given 16 depression 
items, 4 immune biomarkers, and 2 stimulations per cytokine), p-values are not adjusted 
using Bonferroni or other correction. This is because tests are not independent (i.e. immune 
biomarkers positively co-vary), and there is no standard correction involving dependent p-
values. Analyses were conducted with IBM SPSS Statistics 22 and R v2.15.2.
3. Results
3.1. Sample characteristics
Table 1 presents bivariate associations between study variables and depression as a 
dichotomous variable. Compared to individuals scoring <48 (hereafter lower-scorers), those 
scoring ≥48 (high-scorers) have higher median baseline cytokine and CRP concentrations 
(ranging from 17-205%), and higher cytokine responses to ex vivo antigen stimulations, 
particularly with PHA. Median PHA-stimulated responses among high-scorers are 63% 
(TNF-α), 144% (IL-1β), and 69% (IL-6) higher; median LPS-stimulated response is 44% 
higher for IL-6. On average, high-scorers are older, more likely female and have lower BMI; 
subsequent multivariate analyses thus control for these factors.
3.2. Prevalence of emotional, cognitive and somatic symptoms of depression
Emotional symptoms – sadness and crying easily – are experienced habitually by about 90% 
of high-scorers (Table S1). Symptoms containing somatic or cognitive components are also 
prevalent among high-scorers: 86% habitually experience irregular sleeping patterns 
(somatic), 84% feelings of uselessness (cognitive) and 77% persistent negative thoughts 
(cognitive). Prevalence of other somatic and cognitive symptoms, including those containing 
both components, is highly variable among high-scorers, ranging from 1.6% (paranoia/
distrust) to 73.4% (difficulty concentrating). Feelings of uselessness, which in our interview 
includes perceptions of greatly reduced functional ability relative to past years, are 
experienced habitually by 42% of lower-scorers and likely reflects the sample being 
comprised mostly of older adults. Factor analysis did not justify reducing the 16 depression 
items into discrete dimensions (e.g. by whether symptoms contain emotional, cognitive or 
somatic components, or by whether symptoms promote energy conservation), and are thus 
not presented.
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3.3. Is depression associated with greater baseline immune activation?
Among high-scorers, 93% are in the upper quintile of at least one immune activation 
biomarker (TNF-α: ≥12.68 pg/mL; IL-1β: ≥0.22; IL-6: ≥1.91; CRP: ≥5.75 mg/L), compared 
to 60% of lower-scorers (χ2=18.48, p<0.001). Thirty-three percent of high-scorers are in the 
upper quintile of at least two markers compared to 19% of lower-scorers (χ2=4.70, p=0.03).
Depression score is associated with higher TNF-α, IL-6 and CRP, but not IL-1β, after 
controlling for potential confounders (Table 2). Inclusion of all biomarkers as predictors in 
the same model does not yield a significant parameter estimate for any biomarker, although 
in this model depression is most strongly associated with CRP (βlog(CRP)=0.064, p=0.124, 
using controls in Table 2).
To account for the high percentage of IL-1β and IL-6 values below the detection limit (41% 
and 21%, respectively) we regressed each of these cytokines on depression score using Tobit 
models for left-censored data (64)1. We did not find marked differences between estimates 
derived from Tobit and GEE models using the same controls (not shown). We also regressed 
each immune activation biomarker on depression score for each sex to determine whether 
associations were explained by sex differences (Table S2). Associations between biomarkers 
and depression score are stronger and more consistent for women, but CRP is associated 
(p<0.05) with depression in the predicted positive direction for both sexes. In the pooled 
sample we did not find a significant sex*depression score interaction effect on any 
biomarker (all p's >0.05).
We found no evidence that the association between depression and immune activation is 
stronger for individuals with reduced energetic status (i.e. by testing for biomarker*BMI 
interactions and by analyzing sub-samples of BMI categories separately, not shown). We 
also tested for sex*biomarker interactions on depression score but found no significant 
effects.
To examine whether depression is associated with immune activation even after accounting 
for acute infectious status, we repeated GEE analyses excluding participants in the upper 
quintile of leukocyte count (≥10,600 cells/mm3), an independent measure of immune 
activation2. Parameter estimates for all biomarkers are very similar to those reported in 
Table 2 (not shown).
3.4. Are emotional, cognitive and somatic symptoms of depression each associated with 
greater baseline immune activation?
Table S3 presents ORs of habitually experiencing a symptom as a function of cytokine or 
CRP concentration after controlling for potential confounders. Both emotional symptoms are 
associated with higher TNF-α (OR of sadness=1.73, 95% CI: 1.32-2.27; OR of crying 
1Tobit regression treats observations below the detection limit as censored values lying somewhere between zero and the detection 
limit, and adjusts the variance accordingly. Lubin et al. (64) argue that Tobit regression produces unbiased variance estimates, unlike 
several alternatives, when the percentage of measurements below the detection limit is moderate or high.
2While this leukocyte count threshold was used because it does not appeal to reference ranges developed in societies experiencing 
different epidemiological conditions than the Tsimane, it is fairly similar to the NIH-recommended cutoff of 10,000 cells/mm3 (http://
www.nlm.nih.gov/medlineplus/ency/article/003643.htm).
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easily=1.67, 95% CI: 1.33-2.09) and IL-6 (OR of sadness=1.72, 95% CI: 1.31-2.26; OR of 
crying easily=1.36, 95% CI: 1.09-1.70) (Figure 1). Irregular sleep (somatic) is associated 
with higher TNF-α (OR=1.55, 95% CI: 1.22-1.97), IL-1β (OR=1.34, 95% CI: 1.02-1.75), 
and IL-6 (OR=2.25, 95% CI: 1.74-2.91). In addition, three cognitive symptoms – difficulty 
concentrating, pessimism, and feelings of uselessness – are associated with CRP (p<0.05) in 
the predicted positive direction (Table S3; Figure 1), with ORs ranging from 1.35-2.36 per 
SD increase. Feelings of fear/nervousness (somatic-cognitive) are associated with higher 
TNF-α (OR=1.54, 95% CI: 1.13-2.09) and IL-6 (OR=1.54, 95% CI: 1.14-2.08), although 
another somatic-cognitive symptom (reduced interest/lethargy) is both positively and 
negatively associated with a biomarker (CRP and TNF-α, respectively). Two cognitive 
symptoms, including one positively associated with CRP (feelings of uselessness and self-
criticism) are negatively associated with at least one cytokine.
In total, across 64 tests (16 items*4 biomarkers), 22 significant (p<0.05) associations were 
found, of which 18 (82%) were in the predicted positive direction. No symptom was 
associated with significantly higher concentration across all four biomarkers. One somatic 
symptom (irregular sleep) was positively associated with 3/4 biomarkers, and six symptoms 
(two emotional, one somatic, two cognitive, and one somatic-cognitive) were positively 
associated with at least two biomarkers. Two symptoms (one cognitive and one somatic-
cognitive) were both positively and negatively associated with a biomarker.
3.5. Are greater cytokine responses to ex vivo antigen stimulations associated with 
depression?
IL-1β and IL-6 responses to LPS and PHA stimulations are positively associated with 
depression score, with effect sizes ranging from 0.21-0.41 SDs after controlling for potential 
confounders (Table 3). Effect sizes are similar after excluding individuals in the upper 
quintile of leukocyte count (not shown). In this reduced sample, TNF-α response to PHA is 
also positively associated with depression (βDepression score=0.21, p=0.057, same controls, 
n=98). In the full sample, however, for each cytokine and stimulation combination, effect 
sizes are attenuated after standardizing stimulated cytokine response by leukocyte count 
(defined as stimulated cytokine response/leukocyte count; see Table S4). Standardized IL-1β 
responses to LPS and PHA remain associated with depression score (for LPS IL-1β: 
βDepression score=0.25, p=0.010; for PHA IL-1β: βDepression score=0.36, p<0.001), but 
standardized LPS IL-6 response is no longer significant (βDepression score=0.10, p=0.312) and 
standardized PHA IL-6 response is of borderline significance (βDepression score=0.17, 
p=0.069).
No association between stimulated cytokine response (standardized by leukocyte count or 
not) and depression score is in the opposite direction as predicted.
3.6. Are greater cytokine responses to ex vivo antigen stimulation associated with 
emotional, cognitive and somatic symptoms of depression?
Table S5 presents OLS estimates of the effect of habitually experiencing a symptom on 
stimulated cytokine responses after controlling for potential confounders (Table S6 presents 
identical estimates after standardizing stimulated cytokine response by leukocyte count). 
Stieglitz et al. Page 11
Brain Behav Immun. Author manuscript; available in PMC 2016 October 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
While greater responses are associated with emotional, somatic and cognitive symptoms 
(Figure 2), responses are more consistent with the experience of tiredness/weakness 
(somatic). Crying easily (emotional) is associated with both higher unstimulated IL-6 
(Figure 1) and at least one stimulated IL-6 response (Figure 2; Tables S5-S6). For all 
symptoms effects on IL-1β and IL-6 are more consistent than on TNF-α. In total, across 96 
tests (16 items*3 cytokines*2 stimulations) 16 significant associations were found (in Table 
S5; 9 are reported in Table S6), all of which were in the predicted positive direction. Effect 
sizes range from 0.48-1.21 SDs.
4. Discussion
We tested several predictions of the host defense hypothesis of depression among adults in a 
high pathogen population. As uniquely predicted by the host defense hypothesis, depression 
among Tsimane is associated with greater baseline immune activation (P1), particularly 
TNF-α, IL-6, and CRP. The association between depression and greater immune activation 
is therefore not unique to Western populations, as has been suggested previously (33, 34, 
65). This finding challenges the immune dysregulation hypothesis, which posits that pre-
adult priming of the immune system weakens linkages between depression in adulthood and 
inflammation. Furthermore, the fact that depression among Tsimane co-occurs with greater 
baseline immune activation even after excluding from analyses adults with elevated 
leukocyte count (indicative of acute infection) suggests a common physiological mechanism 
linking reduced psychological well-being to low-grade inflammation across diverse 
populations. Longitudinal research will be necessary to determine whether greater systemic 
inflammation due to infection or tissue injury is the mechanism directly leading to 
depression.
Depression among Tsimane is a collection of emotional, somatic, and cognitive symptoms 
(Table S1). While depressive symptoms may vary in their functions (8, 54, 55), we find that 
emotional, somatic, and cognitive symptoms are each associated with greater baseline 
immune activation (Figure 1; Table S3). This preliminarily supports the notion that 
depression is one component of a broader coordinated evolved response to infection or 
injury, i.e. sickness behavior (13), although further research is needed to clarify why certain 
symptoms are more consistently linked to biomarkers of immune activation. Moreover, 
alternative hypothesized functions were not tested and cannot be ruled out; alternative 
functions may complement a host defense function. Empirical research is thus needed to 
determine the function of individual depressive symptoms, and whether symptoms serve 
multiple functions simultaneously. Sadness, for example, may help ego identify and 
withdraw from situations imposing net fitness costs (8, 66), while also promoting energy 
conservation and reallocation through risk aversion. Pessimism may similarly conserve 
energy through diminished initiative while facilitating social withdrawal, which may reduce 
risk of transmitting infection to kin and other valued social partners. These differing 
hypothesized functions are not mutually exclusive and future research should identify and 
test competing predictions generated by the alternative adaptive models of depression. 
Whether depression induces social withdrawal, as predicted by the host defense hypothesis, 
or facilitates social integration, as predicted by the social risk hypothesis (7), is one instance 
in which alternative models generate competing predictions.
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As uniquely predicted by the host defense hypothesis, greater cytokine responses 
(particularly IL-1 and IL-6) to ex vivo antigen stimulations are associated with depression 
among Tsimane adults (P3). Concentrations of both LPS- and PHA-stimulated cytokines 
positively covary with depression score, perhaps suggesting a general role for depression in 
potentiating immunity to both bacterial and viral infection. Consistent with our findings 
linking individual depressive symptoms to baseline immune activation biomarkers (section 
3.4) we find that stimulated biomarkers are associated with emotional, somatic, and 
cognitive symptoms (section 3.6). These associations are evident even for symptoms that do 
not directly promote energy conservation, as in the case of “crying easily” (Figure 2).
We find no evidence of an association between immuno-suppression – as indicated by a 
significantly reduced cytokine response to ex vivo stimulation – and depression or any 
depressive symptom (Tables 3 and S4-6, Figure 2). In Western clinical and community 
samples both immune activation and suppression are associated with depression (15, 67), 
and innate and acquired immunity appear to be involved in complex ways (35, 68, 69). Few 
attempts have been made to categorize immune profile variability among depressed 
individuals, in Western or non-Western populations, in part because evidence of immune 
activation and suppression within the same individual is scant. One untested possibility is 
that more energetically costly aspects of immunity, such as cell-mediated adaptive 
immunity, are more sensitive to the potentiating effects of depression compared to less 
costly innate immune responses.
4.1. Limitations
First, the study design limits our ability to test with sufficient power whether immune 
activation from infection or tissue injury prospectively induces depression, and whether 
depression potentiates immunity in response. We are thus unable to test whether depression 
accelerates recovery rate, as uniquely predicted by the host defense hypothesis. The study 
design also limits our ability to distinguish between host defense responses to acute and 
chronic infectious diseases. Second, we do not test other predictions unique to the host 
defense hypothesis, such as whether depression reduces risk of transmitting infection to kin 
or other valued social partners via social withdrawal. While most of the findings we report 
are not predicted by other adaptive hypotheses of depression, our findings are not 
incompatible with those hypotheses and alternative explanations cannot be ruled out. 
Depression may, for example, function to solicit investment from social partners during 
periods of greater baseline immune activation. Third, we are unable to determine whether 
the results reported here generalize to younger adults, as older adults are over-represented in 
this study. Since selection acts strongly on young adults of reproductive age, if depression is 
indeed an adaptation then it must provide fitness benefits to younger adults (70). Fourth, 
despite a subsistence-based economy and lack of significant public health infrastructure, the 
Tsimane are not pure hunter-gatherers and may differ in important ways from ancestral 
human populations in terms of residential mobility, diet, disease exposures, and other 
factors. Yet no population can represent the range of experiences across different 
environments that shaped the evolution of our species over the millennia in which global 
climates and ecologies fluctuated.
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4.2. Conclusion
The association between depression and greater immune activation is not unique to Western 
populations. Depression exists in the absence of risk factors found in industrialized societies 
including low pathogenic exposures in development, high prevalence of metabolic disorder, 
and high levels of psychosocial stress from rampant economic inequality or social isolation. 
Depression thus appears to be a response to conditions regularly experienced over human 
history, and not simply a by-product of modernity. While reduced psychological well-being 
is associated with poorer health across diverse societies including Tsimane (42, 52, 53, 71), 
depressed Tsimane adults show greater, not reduced, cytokine responses to ex vivo antigen 
stimulation compared to non-depressed adults. These results are consistent with the host 
defense hypothesis of depression. Other adaptive explanations that focus on social benefits 
or benefits from regulation of energy expenditure for nonsocial goals do not explain 
consistent bidirectional associations between depression and greater immune activation. In 
light of our findings, additional longitudinal research will be necessary to isolate and test 
competing predictions generated by the alternative adaptive scenarios of depression and its 
symptoms. Mood research in small-scale societies is useful to determine whether mood 
variation is adaptive, and to advance a more general theoretical framework for 
understanding susceptibility to mood disorders.
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HIGHLIGHTS
• Among Bolivian forager-farmers, depression is associated with immune 
activation
• Emotional, somatic and cognitive symptoms are associated with immune 
activation
• Greater immune response to ex vivo blood stimulation is associated with 
depression
• Greater ex vivo response is linked to emotional, somatic and cognitive 
symptoms
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Figure 1. 
OR (95% CI) of reporting “always” experiencing a symptom compared to “rarely” per SD 
increase in cytokine or CRP concentration (logged). Estimates are derived from multinomial 
logistic regression controlling for age, age2 (if p≤ 0.1), sex, BMI, and region. Symptoms are 
categorized by whether they include emotional (E, black line), somatic (S, gray), or 
cognitive (C, red) components.
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Figure 2. 
Standardized β(95% CI) from OLS regression of the effect of depression item score on 
cytokine response to ex vivo antigen stimulation. Estimates represent the change in 
stimulated cytokine response from reporting “always” experiencing a symptom compared to 
“rarely” controlling for age, sex, BMI, and unstimulated serum cytokine concentration. 
Stimulated cytokine response is standardized by leukocyte count. Cytokine concentrations 
(unstimulated and stimulated) are logged to normalize distributions. Gray lines represent 
IL-1β and red lines IL-6 (solid lines=LPS stimulation, dashed=PHA).
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Table 1
Bivariate associations between study variables and depression as a dichotomous variable (≥48 indicates a 
mean item score ≥3, i.e. “often” experiencing symptom).
Immune activation biomarkers ≥48 (High-scorers, 10%
a
) <48 (Lower-scorers, 90%) N
Cytokine or CRP concentration
    TNF-α (pg/mL) (median)
10.95
*** 8.06 634
    IL-1β (pg/mL) (median)
0.07
^ 0.06 636
    IL-6 (pg/mL) (median)
0.82
** 0.52 649
    CRP (mg/L) (median)
5.49
** 1.80 496
Cytokine response to ex vivo antigen stimulation
    TNF-α (pg/mL)
        LPS-stimulated (median) 143 149 117
        PHA-stimulated (median)
62
^ 38 121
    IL-1β (pg/mL)
        LPS-stimulated (median) 540 468 119
        PHA-stimulated (median)
239
* 98 123
    IL-6 (pg/mL)
        LPS-stimulated (median)
3,719
* 2,589 118
        PHA-stimulated (median)
3,461
* 2,053 124
Controls
    Age (years) (mean±SD)
55.4
^
 ± 11.9
53.0 ± 10.8 649
    % female
72
*** 46 649
    BMI (kg/m2) (mean±SD) 23.5
^
 ± 3.9
24.1 ± 3.3 649
***
p≤0.001
**
p≤0.01
*
p≤0.05
^
p≤0.1 (compared to lower-scorers; Mann-Whitney U or χ2 test)
a
Risk set includes interviewees that provided a morning fasting blood sample (n=649)
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Table 2
GEE analyses of effects of baseline immune activation biomarkers on depression score (summed 16 items) 
controlling for age, sex, BMI and region
a
. Standardized β's are shown (95% CIs for biomarker β's).
Cytokine or CRP concentration Model 1 Model 2 Model 3 Model 4
    log(TNF-α)
0.09
**
 (0.03-0.16)
----- ----- -----
    log(IL-1β) ----- −0.01 (−0.08-0.06) ----- -----
    log(IL-6) ----- -----
0.09
*
 (0.02-0.16)
-----
    log(CRP) ----- ----- -----
0.07
*
 (0.01-0.14)
Controls
    Age (years)
0.74
*
0.79
*
0.94
**
1.10
***
    Age2 −0.63
^
−0.66
^
−0.81
*
−0.93
**
    Sex=female
0.59
***
0.56
***
0.57
***
0.49
***
    BMI (kg/m2) −0.09
*
−0.10
**
−0.09
*
−0.06
^
N observations, individuals 634, 614 636, 613 649, 626 496, 477
***
p≤0.001
**
p≤0.01
*
p≤0.05
^
p≤0.1
a
Parameter estimates for a categorical region fixed effect (1=interior forest, 2=downriver, 3=upriver, 4=near town) are not shown. Significant 
differences in depression score are observed across regions, and region is controlled in each model
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Table 3
OLS regressions of the effect of depression score
a
 on cytokine response to ex vivo antigen stimulation. 
Standardized β's are shown (95% CIs for βDepression score) controlling for age, sex, BMI and unstimulated 
serum cytokine concentration
b,c
.
TNF-α IL-1β IL-6
Parameter LPS-stimulated PHA-stimulated LPS-stimulated PHA-stimulated LPS-stimulated PHA-stimulated
    Depression score 0.09 (−0.12-0.30)
0.16
^
 (−0.04-0.36) 0.32
***
 (0.13-0.51) 0.41
***
 (0.23-0.60) 0.21
*
 (0. 01-0.43) 0.27
**
 (0.07-0.47)
Controls
    Age (years) 0.04 0.09 −0.08 −0.05 −0.06 0.06
    Sex=female −0.20 −0.23
−0.74
***
−0.54
**
−0.30
^
−0.49
**
    BMI (kg/m2) 0.01 0.06 0.08 0.13 0.05 0.02
    log(unstimulated 
serum cytokine 
concentration)
0.15
0.24
* −0.05 −0.08 −0.03 −0.05
Adjusted R2 <0.01 0.06 0.13 0.15 <0.01 0.06
N individuals 117 121 119 123 118 124
***
p≤0.001
**
p≤0.01
*
p≤0.05
^
p≤0.1
a
Summed 16 items
b
95% CIs for controls are not included due to space limitations
c
Cytokine concentrations (unstimulated and stimulated) are logged to normalize distributions
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